TANDEM-IRI-TACE combined with systemic FOLFIRI for colorectal liver metastases after oxaliplatin regimen failure: Phase I dose escalation study

ABSTRACT: Interventions: TACE will be conducted every 5 weeks. Systemic FOLFIRI will be conducted every 2 weeks. Primary outcome(s): Dose Limiting Toxicity,Recommended Dose Study Design: Single arm Non-randomized

DISEASE(S): Colorectal Cancer

PROVIDER: 2630698 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR